CHRNA4 Antikörper (N-Term)
Kurzübersicht für CHRNA4 Antikörper (N-Term) (ABIN926962)
Target
Alle CHRNA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Rind (Kuh), Huhn
-
Aufreinigung
- Purified
-
Immunogen
- CHRNA4 antibody was raised in rabbit using the N terminal of CHRNA4 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CHRNA4 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CHRNA4 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CHRNA4 (Cholinergic Receptor, Nicotinic, alpha 4 (CHRNA4))
-
Andere Bezeichnung
- CHRNA4
-
Hintergrund
- CHRNA4 is a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Synonyms: Polyclonal CHRNA4 antibody, Anti-CHRNA4 antibody, cholinergic receptor, nicotinic, alpha 4 antibody, BFNC antibody, EBN antibody, EBN1 antibody, NACRA4 antibody.
-
Pathways
- Synaptic Membrane
Target
-